Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial

Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial

Generic large Mylan has confronted a slew of lawsuits concentrating on its EpiPen advertising and marketing methods. Now referred to as Viatris, the drugmaker says it is scored a win in opposition to critical expenses... Read more »